Michael Sefton
Technik-/Wissenschafts-/F&E-Leiter bei Therapeutics Chemical Engineering Ltd.
Profil
Michael Sefton is the founder of Rimon Therapeutics Ltd.
He currently holds positions as Director & Chief Scientific Officer at Therapeutics Chemical Engineering Ltd., Professor at the University of Toronto, and Professor at the Institute of Biomaterials & Biomedical Engineering.
Previously, he was Director at PharmEng International, Inc. from 2006 to 2009 and Director at The Health Technology Exchange.
Sefton holds a doctorate from the Massachusetts Institute of Technology and an undergraduate degree from the University of Toronto.
Aktive Positionen von Michael Sefton
| Unternehmen | Position | Beginn |
|---|---|---|
| University of Toronto | Corporate Officer/Principal | - |
| Therapeutics Chemical Engineering Ltd. | Technik-/Wissenschafts-/F&E-Leiter | - |
| Institute of Biomaterials & Biomedical Engineering | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Michael Sefton
| Unternehmen | Position | Ende |
|---|---|---|
PharmEng International, Inc.
 PharmEng International, Inc. Miscellaneous Commercial ServicesCommercial Services PharmEng International, Inc. was a full-service consulting and contract manufacturing company, which serves the pharmaceutical and biotechnology industries. The company was founded on October 1, 2003 and was headquartered in Markham, ON. | Direktor/Vorstandsmitglied | 13.04.2009 |
The Health Technology Exchange
 The Health Technology Exchange Financial ConglomeratesFinance The Health Technology Exchange provides non-dilutive project financing to the medical and assistive technology sector. The company’s programs include Health Technology Commercialization Program (HTCP), REACH Innovation Procurement program and MedTech ecosystem support activities. Its initiatives include The Harmony Project, The HTX Soft Landing Program and Medtech RISE. The company was founded in 2004 and is headquartered in Toronto, Canada. | Direktor/Vorstandsmitglied | - |
Rimon Therapeutics Ltd.
 Rimon Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Rimon Therapeutics Ltd. develops and markets pharmaceutical products. The company was founded by Michael May and is headquartered in Mississauga, Canada. | Gründer | - |
Ausbildung von Michael Sefton
| Massachusetts Institute of Technology | Doctorate Degree |
| University of Toronto | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
PharmEng International, Inc.
PharmEng International, Inc. Miscellaneous Commercial ServicesCommercial Services PharmEng International, Inc. was a full-service consulting and contract manufacturing company, which serves the pharmaceutical and biotechnology industries. The company was founded on October 1, 2003 and was headquartered in Markham, ON. | Commercial Services |
| Therapeutics Chemical Engineering Ltd. | |
Rimon Therapeutics Ltd.
Rimon Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Rimon Therapeutics Ltd. develops and markets pharmaceutical products. The company was founded by Michael May and is headquartered in Mississauga, Canada. | Health Technology |
The Health Technology Exchange
The Health Technology Exchange Financial ConglomeratesFinance The Health Technology Exchange provides non-dilutive project financing to the medical and assistive technology sector. The company’s programs include Health Technology Commercialization Program (HTCP), REACH Innovation Procurement program and MedTech ecosystem support activities. Its initiatives include The Harmony Project, The HTX Soft Landing Program and Medtech RISE. The company was founded in 2004 and is headquartered in Toronto, Canada. | Finance |
